Building A Quality & Safety Infrastructure: The Harris Center Case Study is starting in

The 2025 OPEN MINDS Pitch Day—NeuroSigma

This presentation took place at The 2025 OPEN MINDS Strategy & Innovation Institute. Colin Kealey, President & Chief Executive Officer of NeuroSigma presented their product, The Monarch eTNS System, the first FDA-approved medical device for treating pediatric ADHD.

https://vimeo.com/1094141523?share=copy#t=0

https://soundcloud.com/user-202102826/neurosigma/s-FTNZrne2cpF?si=218048b0b10a40238460a8eda6e46398&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.